Thomas J. Schall, Director at Immuneering Corp (IMRX), bought 80,970 shares at $2.21 ($179K) on 2025-06-17, disclosed to the SEC on 2025-06-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.21 | 40,485 | $89K | 50.0% |
| 2 | $2.21 | 40,485 | $89K | 50.0% |
| Total | $2.21 avg | 80,970 | $179K | 100% |
| Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |
| CCXI | SELL | 2020-12-16 | $3.7M | — | Filing → |